# FDA Inspection 1029767 - CorneaGen, LLC - October 20, 2017

Source: https://www.keypedia.com/records/fda_inspections/corneagen-llc/76a8cbc2-900e-4f16-9779-a52049d30118
Source feed: FDA_Inspections

> FDA Inspection 1029767 for CorneaGen, LLC on October 20, 2017. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1029767
- Company Name: CorneaGen, LLC
- Inspection Date: 2017-10-20
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1231203 - 2024-03-25](https://www.keypedia.com/records/fda_inspections/corneagen-llc/216c4b4a-1c15-40f1-b709-a61c55742955)
- [FDA Inspection 1029767 - 2017-10-20](https://www.keypedia.com/records/fda_inspections/corneagen-llc/2aba32ac-db1e-4ef5-9710-d6345a39e72b)
- [FDA Inspection 944737 - 2015-09-11](https://www.keypedia.com/records/fda_inspections/corneagen-llc/7081d819-2cb3-4474-9802-9700dd0fb5c2)

Company: https://www.keypedia.com/companies/corneagen-llc/0f0be129-a780-411e-a640-7577d666d7cc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d